Stem Cell Therapy Slows Kidney Decline | Galway News

A breakthrough stem cell therapy from Galway-based Orbsen Therapeutics shows early promise in slowing kidney damage from type 2 diabetes—potentially delaying or even preventing the need for dialysis or transplants. In a 18-month trial, a single IV dose of ORBCEL-M preserved kidney function better than expected, sparking optimism for larger studies that could redefine care for millions living with progressive kidney disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8e5a4298b888ee1a